Board Member of Private School Ousted

An alumnus of the Phillips Exeter Academy, in N.H., has successfully ousted the vice president of the school’s board of trustees, Paul Goldenheim, according to the Boston Globe.

Dr. Goldenheim was a vice president and chief medical officer at Purdue Pharma, in Stamford, Conn., when he and the company pleaded guilty to charges of “misbranding” the company’s painkiller OxyContin. The government convicted Purdue of playing down the addictive qualities of the drug.

Before the sentencing, Mr. Goldenheim offered to resign from the academy’s board. When trustees declined to remove him, an Exeter alumnus, whom the newspaper did not name, contacted other Exeter graduates to protest Mr. Goldenheim’s involvement on the board.

Neither the president of the board, Charles Harris, nor Dr. Goldenheim were willing to comment on the matter, the newspaper reported.

(Free registration is required to view this article.)